HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.

AuthorsTadashi Imafuku, Hiroshi Watanabe, Kentaro Oniki, Akira Yoshida, Hiromasa Kato, Takehiro Nakano, Kai Tokumaru, Issei Fujita, Nanaka Arimura, Hitoshi Maeda, Yuki Sakamoto, Nozomi Kondo, Ayami Morita, Junji Saruwatari, Motoko Tanaka, Kazutaka Matsushita, Takashi Wada, Masafumi Fukagawa, Masaki Otagiri, Michael L Fitzgerald, Hideaki Jinnouchi, Toru Maruyama
JournalDiabetes care (Diabetes Care) Vol. 44 Issue 6 Pg. e115-e117 (06 2021) ISSN: 1935-5548 [Electronic] United States
PMID33905348 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Biomarkers
Topics
  • Albumins
  • Albuminuria (diagnosis)
  • Biomarkers
  • Diabetes Mellitus, Type 2 (complications, diagnosis)
  • Diabetic Nephropathies (diagnosis)
  • Disease Progression
  • Humans
  • Kidney
  • Kidney Diseases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: